These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 12919157)

  • 1. Clinical and radiological features of patients with macroprolactinaemia.
    Strachan MW; Teoh WL; Don-Wauchope AC; Seth J; Stoddart M; Beckett GJ
    Clin Endocrinol (Oxf); 2003 Sep; 59(3):339-46. PubMed ID: 12919157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients with macroprolactinaemia: clinical and radiological features.
    Donadio F; Barbieri A; Angioni R; Mantovani G; Beck-Peccoz P; Spada A; Lania AG
    Eur J Clin Invest; 2007 Jul; 37(7):552-7. PubMed ID: 17576206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coexistence of macroprolactinaemia and hyperprolactinaemia in women with oligo-/amenorrhoea is associated with high risk of pituitary adenomas.
    Lewandowski KC; Gasior-Perczak D; Kowalska A; Lewinski A
    Gynecol Endocrinol; 2014 May; 30(5):385-7. PubMed ID: 24533748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for macroprolactinaemia and pituitary imaging studies.
    Hauache OM; Rocha AJ; Maia AC; Maciel RM; Vieira JG
    Clin Endocrinol (Oxf); 2002 Sep; 57(3):327-31. PubMed ID: 12201824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers.
    Hattori N; Ishihara T; Saiki Y
    Clin Endocrinol (Oxf); 2009 Nov; 71(5):702-8. PubMed ID: 19486017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition.
    Olukoga AO; Kane JW
    Clin Endocrinol (Oxf); 1999 Jul; 51(1):119-26. PubMed ID: 10468974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The detection of macroprolactin by precipitation and ultrafiltration methods.
    Beda-Maluga K; Pisarek H; Komorowski J; Pawlikowski M; Świętosławski J; Winczyk K
    Endokrynol Pol; 2011; 62(6):529-36. PubMed ID: 22144220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperprolactinaemia does not always mean 'hyperprolactinaemia'!
    Gezer A; Atasü T; Hekim C; Stenman UH; Hekim N
    Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):206-8. PubMed ID: 15653204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macroprolactinaemia: contribution to hyperprolactinaemia in a district general hospital and evaluation of a screening test based on precipitation with polyethylene glycol.
    Fahie-Wilson MN; Soule SG
    Ann Clin Biochem; 1997 May; 34 ( Pt 3)():252-8. PubMed ID: 9158821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TSH response to domperidone reflects the biological activity of prolactin in macroprolactinaemia and hyperprolactinaemia.
    Pinto LP; Hanna FW; Evans LM; Davies JS; John R; Scanlon MF
    Clin Endocrinol (Oxf); 2003 Nov; 59(5):580-4. PubMed ID: 14616880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should macroprolactin be measured in all hyperprolactinaemic sera?
    McKenna TJ
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):466-9. PubMed ID: 19320649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of hyperprolactinaemia with the use of the intervals for prolactin after macroforms separation.
    Beda-Maluga K; Pisarek H; Komorowski J; Swietoslawski J; Fuss-Chmielewska J; Winczyk K
    J Physiol Pharmacol; 2014 Jun; 65(3):359-64. PubMed ID: 24930507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reference ranges for serum total and monomeric prolactin for the current generation Abbott Architect assay.
    Whitehead SJ; Cornes MP; Ford C; Gama R
    Ann Clin Biochem; 2015 Jan; 52(Pt 1):61-6. PubMed ID: 25074991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A practical method for the detection of macroprolactinaemia using ultrafiltration.
    Prazeres S; Santos MA; Ferreira HG; Sobrinho LG
    Clin Endocrinol (Oxf); 2003 Jun; 58(6):686-90. PubMed ID: 12780743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of prolactin: the macroprolactin problem.
    Fahie-Wilson M; Smith TP
    Best Pract Res Clin Endocrinol Metab; 2013 Oct; 27(5):725-42. PubMed ID: 24094642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Macroprolactin in subjects with hyperprolactinaemia: clinical observations and relations between free PRL and PRL complexed with IgG].
    Jeske W; Zgliczyński W; Gorzelak K
    Endokrynol Pol; 2005; 56(5):779-84. PubMed ID: 16817144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A possible cause of the variable detectability of macroprolactin by different immunoassay systems.
    Hattori N; Aisaka K; Shimatsu A
    Clin Chem Lab Med; 2016 Apr; 54(4):603-8. PubMed ID: 26457779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macroprolactinaemia in patients with hyperprolactinaemia: composition of macroprolactin and stability during long-term follow-up.
    Hattori N; Ishihara T; Saiki Y; Shimatsu A
    Clin Endocrinol (Oxf); 2010 Dec; 73(6):792-7. PubMed ID: 20874771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macroprolactinaemia associated with prolactin adenoma.
    Mounier C; Trouillas J; Claustrat B; Duthel R; Estour B
    Hum Reprod; 2003 Apr; 18(4):853-7. PubMed ID: 12660284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of screening for macroprolactin in all hyperprolactinaemic sera.
    Jamaluddin FA; Sthaneshwar P; Hussein Z; Othman N; Chan SP
    Malays J Pathol; 2013 Jun; 35(1):59-63. PubMed ID: 23817395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.